PFIZER INC
For the period ended Sep 28, 2025. Filed Nov 4, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 28, 2025 · Filed Nov 4, 2025
PFE$29.36+0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Comprehensive Income
| Three Months Ended | Nine Months Ended | |||
|---|---|---|---|---|
| (MILLIONS) | September 28,2025 | September 29,2024 | September 28,2025 | September 29,2024 |
| Net income before allocation to noncontrolling interests | $3,550 | $4,473 | $9,452 | $7,644 |
| Foreign currency translation adjustments, net | 365 | 131 | (66) | 200 |
| Unrealized holding gains/(losses) on derivative financial instruments, net | (1) | (303) | (396) | 41 |
| Reclassification adjustments for (gains)/losses included in net income(a) | 177 | (175) | (242) | (334) |
| 176 | (477) | (638) | (293) | |
| Unrealized holding gains/(losses) on available-for-sale securities, net | (10) | 59 | 124 | (17) |
| Reclassification adjustments for (gains)/losses included in net income(b) | (97) | (6) | (25) | 80 |
| (107) | 54 | 100 | 63 | |
| Reclassification adjustments related to amortization of prior service costs and other, net | (16) | (27) | (70) | (83) |
| Reclassification adjustments related to curtailments of prior service costs and other, net | (5) | (2) | (49) | (2) |
| (21) | (29) | (119) | (85) | |
| Other comprehensive income/(loss), before tax | 413 | (322) | (723) | (115) |
| Tax provision/(benefit) on other comprehensive income/(loss) | 45 | (157) | (492) | (81) |
| Other comprehensive income/(loss) before allocation to noncontrolling interests | $367 | $(166) | $(231) | $(35) |
| Comprehensive income/(loss) before allocation to noncontrolling interests | $3,917 | $4,307 | $9,221 | $7,609 |
| Less: Comprehensive income/(loss) attributable to noncontrolling interests | 4 | (3) | 26 | (2) |
| Comprehensive income/(loss) attributable to Pfizer Inc. | $3,913 | $4,310 | $9,195 | $7,611 |
(a)Reclassified into Other(income)/deductions—netand Cost of sales. See Note 7E.
(b)Reclassified into Other(income)/deductions—net.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.